Search in:

Expert Opinion on Investigational Drugs Volume 30, 2021 - Issue 1

Submit an article Journal homepage

Open access

4,760

Views

CrossRef citations to date

Altmetric

Review

Investigational drugs for the treatment of diffuse large B-cell lymphoma

Andrea PatriarcaDivision of Hematology, Department of Translational Medicine, Università Del Piemonte Orientale and Ospedale Maggiore Della Carità, Novara, ItalyCorrespondence[email protected]

https://orcid.org/0000-0003-4415-2906 View further author information

Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Università Del Piemonte Orientale and Ospedale Maggiore Della Carità, Novara, ItalyCorrespondence[email protected]

https://orcid.org/0000-0002-4681-0151 View further author information

Pages 25-38 | Received 14 Aug 2020, Accepted 20 Nov 2020, Published online: 21 Dec 2020

Cite this article
https://doi.org/10.1080/13543784.2021.1855140
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (20)

Zhijia Zhao, Xiaochen Shen, Siqi Zhao, Jinhua Wang, Yuqin Tian, Xiaobo Wang & Bo Tang. (2023) A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma. Aging 15:22, pages 12927-12951.
Crossref

Cheng Xing, Shicong Zhu, Wenzhe Yan, Hongkai zhu, Zineng Huang, Yan Zhao, Wancheng Guo, Huifang Zhang, Le Yin, Xueqin Ruan, Zeyue Deng, Peilong Wang, Zhao Cheng, Zhihua Wang & Hongling Peng. (2023) Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. Heliyon 9:11, pages e22209.
Crossref

Amreen Salwa, Alessandra Ferraresi, Eleonora Secomandi, Letizia Vallino, Riccardo Moia, Andrea Patriarca, Beatrice Garavaglia, Gianluca Gaidano & Ciro Isidoro. (2023) High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy. Cells 12:15, pages 1924.
Crossref

Frédérique St-Pierre & Leo I Gordon. (2023) Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma. Future Oncology 19:1, pages 19-28.
Crossref

Jing He, Ziwei Chen, Qingfeng Xue, Pingping Sun, Yuan Wang, Cindy Zhu & Wenyu Shi. (2022) Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. Journal of Translational Medicine 20:1.
Crossref

Bo Chen, Tianjiao Mao, Xiuni Qin, Wenqi Zhang, Nobumoto Watanabe & Jiang Li. (2022) Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation. Frontiers in Oncology 12.
Crossref

Lingling Wang, Qian Huang, Jiao Tang, Jun Feng, Yongfen Huang, Jianming Dong, Yuexin Cheng, Hao Xu & Yuqing Miao. (2022) Atypical nontraumatic chylothorax in a monoclonal IgM elevated nodal marginal zone lymphoma: A case report and review of the literature. Frontiers in Immunology 13.
Crossref

Tian Tian, Jiwei Li, Di Shi, Yupeng Zeng, Baohua Yu, Xiaoqiu Li, Ping Wei & Xiaoyan Zhou. (2022) SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription. Cell Death & Disease 13:9.
Crossref

Rossella Benedetti, Andrea Arena, Maria Anele Romeo, Maria Saveria Gilardini Montani, Roberta Gonnella, Roberta Santarelli, Pankaj Trivedi & Mara Cirone. (2022) Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas. International Journal of Molecular Sciences 23:16, pages 9113.
Crossref

Cancan Luo, Tiantian Yu, Ken H. Young & Li Yu. (2022) HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression组蛋白去乙酰化酶(HDAC)抑制剂西达本胺联合维奈托克通过下调MYC、BCL2和TP53的表达协同抑制弥漫性大B细胞淋巴瘤的生长. Journal of Zhejiang University-SCIENCE B 23:8, pages 666-681.
Crossref

Maria-Alexandra Zamfir, Liliana Moraru, Camelia Dobrea, Andreea-Elena Scheau, Simona Iacob, Cosmin Moldovan, Cristian Scheau, Constantin Caruntu & Ana Caruntu. (2022) Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 58:7, pages 874.
Crossref

Shama Jaswal, Vanessa Sanders, Priyanka Pullarkat, Stephanie Teja, Amber Salter, Marcus P. Watkins, Norman Atagu, Daniel R. Ludwig, Joyce Mhlanga, Vincent M. Mellnick, Linda R. Peterson, Nancy L. Bartlett, Brad S. Kahl, Todd A. Fehniger, Armin Ghobadi, Amanda F. Cashen, Neha Mehta-Shah & Joseph E. Ippolito. (2022) Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Cancers 14:12, pages 2932.
Crossref

Kyle C. Roche, Peter A. DeRosa, Min-Ling Liu, Victor E. Nava & Anita Aggarwal. (2022) Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy. Current Oncology 29:6, pages 4117-4124.
Crossref

Wojciech Wiese, Natalia Siwecka, Adam Wawrzynkiewicz, Wioletta Rozpędek-Kamińska, Ewa Kucharska & Ireneusz Majsterek. (2022) IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies. Cancers 14:10, pages 2526.
Crossref

Kubra Acikalin Coskun, Merve Tutar, Elif Cansu Abay, Nazlican Yurekli, Mervenur Al & Yusuf Tutar. 2022. Lymphoma. Lymphoma.

Mohammad Almasri, Marah Amer, Joseph Ghanej, Abdurraouf Mokhtar Mahmoud, Gianluca Gaidano & Riccardo Moia. (2022) Druggable Molecular Pathways in Chronic Lymphocytic Leukemia. Life 12:2, pages 283.
Crossref

Aleksandra Kusowska, Matylda Kubacz, Marta Krawczyk, Aleksander Slusarczyk, Magdalena Winiarska & Malgorzata Bobrowicz. (2022) Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences 23:3, pages 1501.
Crossref

Eun Ji Han, Joo Hyun O, Hyukjin Yoon, Seunggyun Ha, Ie Ryung Yoo, Jae Won Min, Joon-Il Choi, Byung-Ock Choi, Gyeongsin Park, Han Hee Lee, Young-Woo Jeon, Gi-June Min & Seok-Goo Cho. (2022) Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics. Diagnostics 12:1, pages 222.
Crossref

Zi-qi Chen, Zhe-rui Cao, Yi Wang, Xi Zhang, Lan Xu, Yu-xiang Wang, Yi Chen, Chun-hao Yang, Jian Ding & Ling-hua Meng. (2022) Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kα against B cell lymphoma. Cancer Letters 524, pages 206-218.
Crossref

Pier Luigi Zinzani & Giorgio Minotti. (2021) Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology 148:1, pages 177-190.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Investigational drugs for the treatment of diffuse large B-cell lymphoma

Articles from other publishers (20)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Investigational drugs for the treatment of diffuse large B-cell lymphoma

Citations (20)

Articles from other publishers (20)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date